Mucoactive drugs
Journal Title: Alergoprofil - Year 2010, Vol 6, Issue 1
Abstract
The production of mucus is the first-line defense against inhaled harmful agents damaging the airway epithelium. The process in which airway mucus together with microbes, viruses and other particles trapped within is moved out of the respiratory tract, is termed mucociliary clearance. The effective ciliary movement and biophysical properties of mucus, especially its two features; viscosity and elasticity, affect on efficiency of this process. Under normal conditions airway mucus protects the lower respiratory tract against inhaled irritants. On the other hand, excessive production of airway mucus in respiratory diseases, such as chronic obstructive pulmonary disease, asthma or cystic fibrosis, is associated with number of complications. Mucus hypersecretion, related with changes in its biophysical properties, can weaken mucociliary clearance as well as favour accumulation of mucus in upper and lower airways. Mucoactive drugs, stimulating airway clearance, are one of the therapeutic options in these cases. According to the putative mechanism of action, these compounds are categorized to four main groups, as expectorants (induce cough), mucolytics (increase mucus viscosity), mucokinetics (facilitate ciliary movement) and mucoregulators (act on hypersecretion). It is noteworthy, that many of them have other beneficial effects besides influence on mucus and mucociliary clearance. For example, the experimental and clinical studies on erdosteine indicate its antioxidant, anti-inflammatory, antibacterial and mucolytic pharmacological activities. Although over 50 compounds have potentially profitable effect on airway mucus, the mechanism of action of numerous of it is imprecisely characterized or absolutely unknown. The accessible data does not interchangeably confirm benefits from use of mucoactive drugs, that is why the further studies on efficacy of its action should be carrying out.
Authors and Affiliations
Anna Zasowska-Nowak, Dariusz Nowak
Keywords
Related Articles
- EP ID EP97191
- DOI -
- Views 74
- Downloads 0
Alergeny pyłku komosy
Sezon pylenia komosy w Polsce rozpoczyna się zwykle w lipcu i trwa w zależności od regionu do końca września. Autor przedstawia aktualny stan wiedzy na temat alergenów pyłku komosy i omawia ich znaczenie w etiologii aler...
Alergeny pyłku grabu
Sezon pylenia grabu w Polsce rozpoczyna się zwykle z końcem kwietnia i trwa w zależności od regionu do połowy maja. Pyłek grabu osiąga niskie i średnie stężenia w atmosferze. Autor prezentuje aktualny stan wiedzy na tema...
Alergogenne znaczenie pyłku mniszka
Sezon pylenia mniszka w Polsce rozpoczyna się zwykle w końcu marca i trwa, w zależności od regionu, do końca maja. Autorzy przedstawiają aktualny stan wiedzy na temat alergenów pyłku mniszka i omawiają ich znaczenie w al...
Thermovision in the diagnosis of nasal and paranasal sinus diseases – preliminary report
The authors present preliminary results of comparative thermovision and computer tomography studies in patients with nasal and paranasal sinus diseases.
Yew and juniper pollen in the air of selected Polish cities<br /> in 2009. The influence of meteorological factors and air pollution
The objective of the studies was to compare the pollen seasons of yew and juniper in the cities of Szczecin, Wrocław, Bydgoszcz, Lublin, Kraków, Warsaw and Sosnowiec in 2009 and to determinate an influence of meteorolog...